Login / Signup

A multicenter randomized placebo-controlled trial of intravenous thyroxine for heart-eligible brain-dead organ donors.

Rajat DharDean KlinkenbergGary Marklin
Published in: Trials (2021)
ClinicalTrials.gov NCT04415658 . Registered on June 4, 2020.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • resting state
  • phase iii
  • white matter
  • heart failure
  • high dose
  • phase ii
  • study protocol
  • functional connectivity
  • cerebral ischemia
  • kidney transplantation
  • cross sectional